IL1-blocking therapy in colchicine-resistant familial Mediterranean fever.

Kucuksahin O, et al.

Clin Exp Rheumatol · 2018

Key Findings

  • Rapid (2-3 days) and persistent suppression of FMF symptoms
  • Significant reduction in attack frequency (P<0.003)
  • Well tolerated over median 2 years

Referenced in (1 disease)

Validation history

Full log →
  1. passsource metadataJun 1, 2026, 04:40 PMby pubmed-api

    Identifier corrected: prior entry (pmid-30418119) had a wrong PMID/DOI pointing to an unrelated paper; re-resolved by title to this record via PubMed/Crossref.

    tools: pubmed.esummary, crossref.works

ID: pmid-30501849DOI: 10.5152/eurjrheum.2018.18036PMID: 30501849